Novo Nordisk to spend $747M+ on expansions and new facility in Denmark
The Danish pharma giant Novo Nordisk is making a major expansion close to home.
The company announced on Tuesday that it plans to invest 5.4 billion Danish kroner ($747.2 million) into expanding its existing facilities in its hometown of Bagsværd, Denmark, a suburb of Copenhagen. Those plans also include the construction of a new plant.
A Novo Nordisk spokesperson did not confirm the size of the new plant to Endpoints News by press time. However, they did tell Endpoints that despite the expansion of existing facilities, the manufacturing of active pharmaceutical ingredients (API) is currently ongoing to support clinical trials. The expansions are expected to be finalized and fully operational in August of next year for purification. The new facility, which is centered around fermentation and recovery, is expected to be finalized in August 2024.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.